← Open Payments lookup

JUSTIN HASLAM: Open Payments

NPI 1033729512 · OGDEN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$773 in 45 payments from 19 companies in 2025. Trend: 2023 $885 · 2024 $931 · 2025 $773

Food & beverage: $773
CompanyPaymentsAmount
ABBVIE INC.12$148
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$135
Lilly USA, LLC5$78
AstraZeneca Pharmaceuticals LP4$65
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$39
GlaxoSmithKline, LLC.2$35
SI-BONE, INC.1$27
Amgen Inc.1$25
Sumitomo Pharma America, Inc.1$25
Lundbeck LLC1$24

Products named: CAPLYTA, MOUNJARO, VRAYLAR, UBRELVY, QULIPTA, XIFAXAN, FARXIGA, TRELEGY ELLIPTA.

Industry payments across UT — which companies pay providers there.